Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetically stratified double-blind trial of posaconazole versus fluconazole prophylaxis in AML/MDS transformation
2019-001585-15Phase 4Active
- Sponsor
- Lausanne University Hospital
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Invasive Mold Infections (IMIs) comparing Posaconazole prophylaxis with Fluconazole prophylaxis (2 arms). Primary endpoint: Cumulative incidence of proven and probable invasive mold infection. Started Dec 2019; status: active.
02
Drugs
posaconazolefluconazole
03
Conditions
Invasive Mold Infections (IMIs)
Beyond the preview
Go deeper on 2019-001585-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001585-15.